Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana
Conditions: Pre-Exposure Prophylaxis (PrEP); Breast Feeding Intervention: Drug: Cabotegravir Injection [Apretude] Sponsors: Beth Israel Deaconess Medical Center; Botswana Harvard AIDS Institute Partnership; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); ViiV Healthcare Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials